How do I subscribe to ongoing alerts?

Subscribe to /feed/company/nucleo-de-pesquisa-e-desenvolvimento-de-medicamentos-da-universidade-federal-do.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara pipeline: 1 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Alpha-lipoic acid	Alpha-lipoic acid	marketed	Antioxidant / Mitochondrial cofactor		Metabolic / Endocrinology
Silver Sulfadiazine Cream 1%	Silver Sulfadiazine Cream 1%	phase 3	Topical antibacterial agent		Dermatology

Therapeutic area mix

Dermatology · 1
Metabolic / Endocrinology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara:

Cite this brief

Drug Landscape (2026). Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/nucleo-de-pesquisa-e-desenvolvimento-de-medicamentos-da-universidade-federal-do. Accessed 2026-05-17.